This new drug, suzetrigine, looks like a spinoff of anticonvulsants (lamotrigine has been on the market for many years) and we really are getting down to the molecular level, aren’t we?
(This is one reason why I am seriously thinking about putting my licenses on inactive status in 2026, something I always told myself I would never do.)